Idealab: Long-term effects of Aβ42 immunisation in Alzheimer’s disease

  • October 2, 2013 · 5:30 PM
  • Ahnon's

Come join IdeaLab, the global DIYbio Journal Club. Every other week, we will be discussing in detail a recent paper from the bioscience literature, with online participants from Counter Culture Labs, BioCurious, Genspace, and other DIYbio groups.

This week, John Schloendorn will be reviewing the following paper:

Long-term effects of Aβ42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial

Clive Holmes, et al.

Summary: Background Immunisation of patients with Alzheimer’s disease with full-length amyloid-β peptide (Aβ42) can clear amyloid plaques from the brain. Our aim was to assess the relation between Aβ42 immune response, degree of plaque removal, and long-term clinical outcomes.

One claim made in the paper is that patients "with virtually complete plaque removal, had severe end stage dementia." John would like us to discuss this claim, and determine if really supported by the data. If yes, how? If not, what else might the data mean?

Look forward to a wonderful discussion. Please make sure to make a account to join the discussion, or join us in person at Ahnon's.

Join or login to comment.

6 went

People in this
Meetup are also in:

Imagine having a community behind you

Get started Learn more

We just grab a coffee and speak French. Some people have been coming every week for months... it creates a kind of warmth to the group.

Rafaël, started French Conversation Group

Start your Meetup today

Act now and get 50% off.
Until February 1.

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy